関連する実験動画
Updated: May 21, 2026
10:28
Body Composition and Metabolic Caging Analysis in High Fat Fed Mice
Published on: May 24, 2018
減量維持期間中のエネルギー消費に対する食事組成の影響
Cara B Ebbeling1, Janis F Swain, Henry A Feldman
1New Balance Foundation Obesity Prevention Center, Children's Hospital Boston, 300 Longwood Ave, Boston, MA 02115, USA.
JAMA
|June 28, 2012
まとめ
減量維持は,エネルギー消費量が減ったため,困難です. 非常に低炭水化物ダイエットは,肥満の成人の低脂肪または低血糖指数ダイエットと比較して,この減少を最小限に抑えました.
科学分野:
- メタボリック・ヘルス (代謝の健康)
- 栄養科学 栄養学 栄養科学は,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学が,栄養学は,栄養学が,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は,栄養学は
- 肥満に関する研究
背景:
- 減量後のエネルギー消費の減少は,体重回復の重要な要因です.
- 体重維持中のエネルギー消費に対する食事組成の影響は十分に理解されていません.
研究 の 目的:
- 異なるマクロ栄養素プロファイルと糖質負荷を持つ3つのダイエットが,減量後のエネルギー消費にどのように影響するか調査する.
- 体重維持中の代謝パラメータに対する低脂肪,低血糖指数,非常に低炭水化物ダイエットの効果を比較する.
主な方法:
- 21人の過体重/肥満の成人を対象とした3方向のクロスオーバー試験.
- 参加者は10〜15%の体重減少を達成し,その後,4週間ごとにイソカロリーダイエット (低脂肪,低血糖指数,非常に低炭水化物) を摂取しました.
- プライマリアウトカム:休憩時のエネルギー支出 (REE);二次アウトカム:総エネルギー支出 (TEE),ホルモン,メタボリックシンドロームの成分.
主要な成果:
- REEとTEEの減少は,低脂肪食で最大で,非常に低炭水化物食で最小でした.
- 重要な傾向は,低血糖負荷のダイエットがエネルギー支出の削減を小さくすることを示しました.
- ホルモンレベルとメタボリックシンドロームの成分は食事によって変化したが,一貫した好ましいパターンは現れなかった.
結論:
- 体重減少の後,非常に低炭水化物ダイエットは,低脂肪および低血糖指数ダイエットと比較して,エネルギー支出の最小の減少につながりました.
- 食事の組成は,体重維持中のエネルギー消費に大きく影響を与えます.
- これらの発見は,マクロ栄養素の組成が体重の回復を防ぐ上で重要な役割を果たすことを示唆しています.
関連する概念動画
01:19Energy Balance
The human body gets energy from the three macronutrients: carbohydrates, proteins, and fats. Energy is released when the chemical bonds in the organic compounds present in the food are broken down. The energy content of food is measured in kilocalories (kcal), defined as the amount of heat required to raise the temperature of one kilogram of water by one degree Celsius. This value is determined by measuring the temperature change of the water surrounding a calorimeter after the complete...
01:30Regulation of Food Intake
Short-term regulation of food intake primarily involves neural signals from the gastrointestinal (GI) tract, blood nutrient levels, and GI tract hormones. Communication between the gut and brain via vagal nerve fibers plays a significant role in evaluating the contents of the gut. Clinical studies have shown that protein ingestion produces a more prolonged response in these nerve fibers compared to an equivalent amount of glucose. Additionally, the activation of stretch receptors caused by GI...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:18Metabolic States of the Body: The Postabsorptive State
The postabsorptive state usually starts about four hours after a meal and lasts until the next meal is eaten. During this time, the digestive system stops absorbing nutrients, and the body uses stored energy reserves to maintain stable blood glucose levels.
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
Initially, glycogen stored in the liver is broken down to release glucose into the bloodstream, while glycogen in the muscles is broken down to supply glucose for energy directly within the muscle cells. As glycogen stores diminish,...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...